Hamza, E., Rezk, S. (2022). EFFECTIVE TREATMENT OF MENINGITIS CAUSED BY MULTIPLE ORGANISMS INCLUDING MDR E. COLI, MDR KLEBSIELLA PNEUMONIAE AND MRSA: A CASE REPORT. Journal of the Medical Research Institute, 43(2), 9-12. doi: 10.21608/jmalexu.2022.307268
Eman Hamza; Shahinda Rezk. "EFFECTIVE TREATMENT OF MENINGITIS CAUSED BY MULTIPLE ORGANISMS INCLUDING MDR E. COLI, MDR KLEBSIELLA PNEUMONIAE AND MRSA: A CASE REPORT". Journal of the Medical Research Institute, 43, 2, 2022, 9-12. doi: 10.21608/jmalexu.2022.307268
Hamza, E., Rezk, S. (2022). 'EFFECTIVE TREATMENT OF MENINGITIS CAUSED BY MULTIPLE ORGANISMS INCLUDING MDR E. COLI, MDR KLEBSIELLA PNEUMONIAE AND MRSA: A CASE REPORT', Journal of the Medical Research Institute, 43(2), pp. 9-12. doi: 10.21608/jmalexu.2022.307268
Hamza, E., Rezk, S. EFFECTIVE TREATMENT OF MENINGITIS CAUSED BY MULTIPLE ORGANISMS INCLUDING MDR E. COLI, MDR KLEBSIELLA PNEUMONIAE AND MRSA: A CASE REPORT. Journal of the Medical Research Institute, 2022; 43(2): 9-12. doi: 10.21608/jmalexu.2022.307268
EFFECTIVE TREATMENT OF MENINGITIS CAUSED BY MULTIPLE ORGANISMS INCLUDING MDR E. COLI, MDR KLEBSIELLA PNEUMONIAE AND MRSA: A CASE REPORT
1Department of Paediatrics, Alexandria University, Faculty of Medicine, El-Shatby Hospital, Alexandria, Egypt.
2Microbiology Department, Medical Research Institute, Alexandria University, Alexandria, Egypt
Abstract
Following neurosurgical intervention, meningitis caused by resistant microorganisms progresses with substantial morbidity and mortality. Treatment is challenging because there are few antibiotics that can cross into the cerebrospinal fluid and act on these organisms. It is advised to administer intraventricular antibiotics in the treatment of meningitis. Hereby, we are presenting a 2-month-old infant presented to the hospital with fever, hypoactivity and decrease in oral intake. This infant had inserted a shunt a month before this presentation. Upon full examination, the infant was diagnosed to suffer from a meningitis caused by multiple organisms including MRSA, MDR E. coli and MDR Klebsiella pneumoniae. The infection was successfully managed with a combination therapy which included, vancomycin, meropenem, amikacin and later on colistin through different routes of administration.